General Healthcare - European Medical Journal

This site is intended for healthcare professionals

Continue

General Healthcare

Filter
EMJ
18 May 2015

Exercise, However Modest, Found Progressively Beneficial to the Elderly

15 May 2015, Lisbon, Portugal. Even exercise of short duration and low intensity has life expectancy benefits for the elderly. Such conclusions have been…
EMJ
14 May 2015

Success of Colorectal Cancer Screening Programmes May Be Pushing Endoscopy Services to Breaking Point

(May 14, 2015) Successful implementation of pan-European colorectal cancer (CRC) screening programmes may be pushing endoscopy services to the limit…
EMJ
14 May 2015

Recommended Levels of Activity Rarely Achieved in Busy Workplace Environment

Even a busy job may not provide enough exercise to meet current activity recommendations for the prevention of cardiovascular disease, according to…
EMJ
11 May 2015

Medac GmbH supports Guideline on Intravesical Instillations of BCG/MMC

Hamburg / Wedel (11 May 2015). medac GmbH has provided the European Association of Urology Nurses (EAUN) with an unrestricted educational grant to…
EMJ
5 May 2015

New Test Predicts Sudden Cardiac Death in Hemodialysis Patients

A new test has been developed to predict sudden cardiac death in hemodialysis patients in whom such forecasts were previously impossible.
EMJ
9 Mar 2015

Basilea Reports U.S. FDA Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

Basel, Switzerland, March 9, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) approved…
EMJ
4 Mar 2015

Saving Precious Time: Siemens’ New Ultrasound System for Faster Imaging

At this year’s European Congress of Radiology (ECR) in Vienna, Austria, Siemens Healthcare introduces its new hand-carried Acuson P500 ultrasound system…
EMJ
27 Feb 2015

Gilead Announces SVR12 Rates from Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily…
We’ve noticed you’re accessing
from North/South America.